LIMS
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
117
NCT06582277
Safety and Immunogenicity of Two Dose Levels of OVX836 Influenza Vaccine as a Booster on Participants Previously Administered With OVX836
Phase: Phase 2
Role: Collaborator
Start: Oct 22, 2024
Completion: Jun 2, 2025
Loading map...